Which osteoporosis medication is administered by subcutaneous injection every six months?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $25.99Unlock all

Prepare for the Musculoskeletal and Medication Test with comprehensive flashcards and multiple-choice questions, complete with hints and detailed explanations. Ace your exam!

Multiple Choice

Which osteoporosis medication is administered by subcutaneous injection every six months?

Explanation:
The question is testing knowledge of how osteoporosis drugs are given and how often. Denosumab fits this description because it’s a monoclonal antibody that inhibits RANKL, reducing osteoclast activity, and is given as a subcutaneous injection every six months. The other options differ in either route or dosing: oral bisphosphonates like alendronate and risedronate are taken by mouth on a weekly or monthly schedule, and zoledronic acid is given by IV infusion typically once a year.

The question is testing knowledge of how osteoporosis drugs are given and how often. Denosumab fits this description because it’s a monoclonal antibody that inhibits RANKL, reducing osteoclast activity, and is given as a subcutaneous injection every six months. The other options differ in either route or dosing: oral bisphosphonates like alendronate and risedronate are taken by mouth on a weekly or monthly schedule, and zoledronic acid is given by IV infusion typically once a year.

More Multiple Choice Questions
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy